📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: HRA Pharma

1.1 - Company Overview

HRA Pharma Logo

HRA Pharma

Headquarter: France
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of drugs, devices, and services in reproductive health and endocrine diseases, offering products such as Norlevo for emergency contraception; Cicatridine for vaginitis and vaginal injury; Delidose, Divina, and Duova for hormone replacement therapy; and GyMiso for cervical ripening.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to HRA Pharma

Alltrna Logo

Alltrna

HQ: United States Website
  • Description: Provider of a tRNA therapeutics platform that uses machine learning and high-throughput proprietary in vitro assays to design and optimize therapeutic tRNA molecules for diseases with genetic mutations. Solutions include tRNA medicines that read stop codons to restore full-length protein production, with data-integrated workflows to refine predictive design.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Alltrna company profile →
The Medicines Company Logo

The Medicines Company

HQ: United States Website
  • Description: Provider of innovative, cost-effective medicines to the worldwide hospital marketplace, focused on advancing treatment of critical care patients. Markets Angiomax(R) (bivalirudin) in the United States and other countries for use in patients undergoing coronary angioplasty, and Cleviprex(R).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full The Medicines Company company profile →
Innate Pharma Logo

Innate Pharma

HQ: France Website
  • Description: Provider of first-in-class immunotherapy drug candidates for cancer and inflammatory diseases, specializing in novel monoclonal antibodies and NK cell engagers targeting innate immunity pathways. Pipeline includes ANKET; Lacutamab for cutaneous and peripheral T cell lymphomas; Monalizumab (anti-NKG2A) and CD39 with AstraZeneca for NSCLC and other solid tumors; CD123 and B7-H3 multi-specific ANKETs with Sanofi.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Innate Pharma company profile →
Synaptogenix Logo

Synaptogenix

HQ: United States Website
  • Description: Provider of clinical-stage biopharmaceutical therapies in development for neurodegenerative diseases, using bryostatin to promote neuronal health and synaptic regeneration.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Synaptogenix company profile →
Abbott Logo

Abbott

HQ: United States Website
  • Description: Provider of pharmaceuticals and healthcare products, including the FreeStyle Libre continuous glucose monitoring system for diabetes management, the MUAC z-score tape for assessing child nutritional status, and COVID-19 antibody testing to detect past infection.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Abbott company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for HRA Pharma

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to HRA Pharma

2.2 - Growth funds investing in similar companies to HRA Pharma

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for HRA Pharma

4.2 - Public trading comparable groups for HRA Pharma

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to HRA Pharma

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About HRA Pharma

What does HRA Pharma do?

HRA Pharma is a provider of drugs, devices, and services in reproductive health and endocrine diseases, offering products such as Norlevo for emergency contraception; Cicatridine for vaginitis and vaginal injury; Delidose, Divina, and Duova for hormone replacement therapy; and GyMiso for cervical ripening.

Who are HRA Pharma's competitors?

HRA Pharma's competitors and similar companies include Alltrna, The Medicines Company, Innate Pharma, Synaptogenix, and Abbott.

Where is HRA Pharma headquartered?

HRA Pharma is headquartered in France.

How many employees does HRA Pharma have?

HRA Pharma has 1,000 employees 🔒.

When was HRA Pharma founded?

HRA Pharma was founded in 2010 🔒.

What sector and industry vertical is HRA Pharma in?

HRA Pharma is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for HRA Pharma

Who are the top strategic acquirers in HRA Pharma's sector and industry

Top strategic M&A buyers and acquirers in HRA Pharma's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for HRA Pharma?

Top strategic M&A buyers groups and sectors for HRA Pharma include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in HRA Pharma's sector and industry vertical

Which are the top PE firms investing in HRA Pharma's sector and industry vertical?

Top PE firms investing in HRA Pharma's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in HRA Pharma's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in HRA Pharma's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in HRA Pharma's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to HRA Pharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in HRA Pharma's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for HRA Pharma?

The key public trading comparables and valuation benchmarks for HRA Pharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for HRA Pharma for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for HRA Pharma with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in HRA Pharma's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for HRA Pharma with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in HRA Pharma's' sector and industry vertical?

Access recent funding rounds and capital raises in HRA Pharma's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for HRA Pharma